Prevalence and Risk Factors Associated with the Occurrence of Autoimmune Diseases in Patients with Alopecia Areata

References

• Safavi K. Prevalence of alopecia areata in the first national health and nutrition examination survey. Arch Dermatol. 1992;128(5):702. doi:10.1001/archderm.1992.01680150136027
   PubMedGoogle Scholar
• Mirzoyev SA, Schrum AG, Davis MDP, Torgerson RR. Lifetime incidence risk of alopecia areata estimated at 2.1% by Rochester epidemiology project, 1990–2009. J Invest Dermatol. 2014;134(4):1141–1142. doi:10.1038/jid.2013.464
   PubMed Web of Science ®Google Scholar
• Strazzulla LC, Wang EHC, Avila L, et al. Alopecia areata: disease characteristics, clinical evaluation, and new perspectives on pathogenesis. J Am Acad Dermatol. 2018;78(1):1–12. doi:10.1016/j.jaad.2017.04.1141
   PubMed Web of Science ®Google Scholar
• Rattananukrom T, Suchonwanit P. Are drug treatment strategies really effective against alopecia areata? Expert Opin Pharmacother. 2021;22(3):257–260. doi:10.1080/14656566.2020.1854728
   PubMed Web of Science ®Google Scholar
• Khunkhet S, Vachiramon V, Suchonwanit P. Trichoscopic clues for diagnosis of alopecia areata and trichotillomania in Asians. Int J Dermatol. 2017;56(2):161–165. doi:10.1111/ijd.13453
   PubMed Web of Science ®Google Scholar
• Meephansan J, Thummakriengkrai J, Ponnikorn S, Yingmema W, Deenonpoe R, Suchonwanit P. Efficacy of topical tofacitinib in promoting hair growth in non-scarring alopecia: possible mechanism via VEGF induction. Arch Dermatol Res. 2017;309(9):729–738. doi:10.1007/s00403-017-1777-5
   PubMed Web of Science ®Google Scholar
• Islam N, Leung PS, Huntley AC, Gershwin ME. The autoimmune basis of alopecia areata: a comprehensive review. Autoimmun Rev. 2015;14(2):81–89. doi:10.1016/j.autrev.2014.10.014
   PubMed Web of Science ®Google Scholar
• Tosti A, Morelli R, Bardazzi F, Peluso AM. Prevalence of nail abnormalities in children with alopecia areata. Pediatr Dermatol. 1994;11(2):112–115. doi:10.1111/j.1525-1470.1994.tb00562.x
   PubMed Web of Science ®Google Scholar
• Alkhalifah A, Alsantali A, Wang E, McElwee KJ, Shapiro J. Alopecia areata update: part I. Clinical picture, histopathology, and pathogenesis. J Am Acad Dermatol. 2010;62(2):177–188, quiz 189–190. doi:10.1016/j.jaad.2009.10.032
   Web of Science ®Google Scholar
• Gilhar A, Ullmann Y, Berkutzki T, Assy B, Kalish RS. Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice. J Clin Invest. 1998;101(1):62–67. doi:10.1172/JCI551
   PubMed Web of Science ®Google Scholar
• Suchonwanit P, Hector CE, Bin Saif GA, McMichael AJ. Factors affecting the severity of central centrifugal cicatricial alopecia. Int J Dermatol. 2016;55(6):e338–343. doi:10.1111/ijd.13061
   PubMed Web of Science ®Google Scholar
• Suchonwanit P, McMichael AJ. Alopecia in association with malignancy: a review. Am J Clin Dermatol. 2018;19(6):853–865. doi:10.1007/s40257-018-0378-1
   PubMed Web of Science ®Google Scholar
• Rajabi F, Drake LA, Senna MM, Rezaei N. Alopecia areata: a review of disease pathogenesis. Br J Dermatol. 2018;179(5):1033–1048. doi:10.1111/bjd.16808
   PubMed Web of Science ®Google Scholar
• Petukhova L, Duvic M, Hordinsky M, et al. Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature. 2010;466(7302):113–117. doi:10.1038/nature09114
   PubMed Web of Science ®Google Scholar
• Ikeda T. Produced alopecia areata based on the focal infection theory and mental motive theory. Dermatologica. 1967;134(1):1–11. doi:10.1159/000254233
   PubMedGoogle Scholar
• Chu SY, Chen YJ, Tseng WC, et al. Comorbidity profiles among patients with alopecia areata: the importance of onset age, a nationwide population-based study. J Am Acad Dermatol. 2011;65(5):949–956. doi:10.1016/j.jaad.2010.08.032
   PubMed Web of Science ®Google Scholar
• Leerunyakul K, Suchonwanit P. Asian Hair: a Review of Structures, Properties, and Distinctive Disorders. Clin Cosmet Investig Dermatol. 2020;13:309–318. doi:10.2147/ccid.S247390
   PubMed Web of Science ®Google Scholar
• Lee S, Lee H, Lee CH, Lee WS. Comorbidities in alopecia areata: a systematic review and meta-analysis. J Am Acad Dermatol. 2019;80(2):466–477 e416. doi:10.1016/j.jaad.2018.07.013
   PubMed Web of Science ®Google Scholar
• Barahmani N, Schabath MB, Duvic M. National Alopecia Areata R. History of atopy or autoimmunity increases risk of alopecia areata. J Am Acad Dermatol. 2009;61(4):581–591. doi:10.1016/j.jaad.2009.04.031
   PubMed Web of Science ®Google Scholar
• Leerunyakul K, Suchonwanit P. Evaluation of hair density and hair diameter in the adult Thai population using quantitative trichoscopic analysis. Biomed Res Int. 2020;2020:2476890. doi:10.1155/2020/2476890
   PubMed Web of Science ®Google Scholar
• Suchonwanit P, Triamchaisri S, Wittayakornrerk S, Rattanakaemakorn P. Leprosy Reaction in Thai Population: a 20-year retrospective study. Dermatol Res Pract. 2015;2015:253154. doi:10.1155/2015/253154
   PubMedGoogle Scholar
• Hayter SM, Cook MC. Updated assessment of the prevalence, spectrum and case definition of autoimmune disease. Autoimmun Rev. 2012;11(10):754–765. doi:10.1016/j.autrev.2012.02.001
   PubMed Web of Science ®Google Scholar
• Safavi KH, Muller SA, Suman VJ, Moshell AN, Melton LJ. Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. Mayo Clin Proc. 1995;70(7):628–633. doi:10.4065/70.7.628
   PubMed Web of Science ®Google Scholar
• Ahmed I, Nasreen S, Bhatti R. Alopecia areata in children. J Coll Physicians Surg Pak. 2007;17(10):587–590. doi:10.2007/JCPSP.587590
   PubMed Web of Science ®Google Scholar
• Sharma VK, Kumar B, Dawn G. A clinical study of childhood alopecia areata in Chandigarh, India. Pediatr Dermatol. 1996;13(5):372–377. doi:10.1111/j.1525-1470.1996.tb00703.x
   PubMed Web of Science ®Google Scholar
• Huang KP, Mullangi S, Guo Y, Qureshi AA. Autoimmune, atopic, and mental health comorbid conditions associated with alopecia areata in the United States. JAMA Dermatol. 2013;149(7):789–794. doi:10.1001/jamadermatol.2013.3049
   PubMed Web of Science ®Google Scholar
• Goh C, Finkel M, Christos PJ, Sinha AA. Profile of 513 patients with alopecia areata: associations of disease subtypes with atopy, autoimmune disease and positive family history. J Eur Acad Dermatol Venereol. 2006;20(9):1055–1060. doi:10.1111/j.1468-3083.2006.01676.x
   PubMed Web of Science ®Google Scholar
• Cunliffe WJ, Hall R, Stevenson CJ, Weightman D. Alopecia areata, thyroid disease and autoimmunity. Br J Dermatol. 1969;81(12):877–881. doi:10.1111/j.1365-2133.1969.tb15967.x
   PubMed Web of Science ®Google Scholar
• You HR, Kim SJ. Factors associated with severity of alopecia areata. Ann Dermatol. 2017;29(5):565–570. doi:10.5021/ad.2017.29.5.565
   PubMed Web of Science ®Google Scholar
• Gregersen PK, Olsson LM. Recent advances in the genetics of autoimmune disease. Annu Rev Immunol. 2009;27:363–391. doi:10.1146/annurev.immunol.021908.132653
   PubMed Web of Science ®Google Scholar
• Ahmed AM, Barahmani N, Duvic M. National Alopecia Areata R. Familial alopecia areata and chronic thrombocytopenia. J Am Acad Dermatol. 2008;58(5 Suppl 1):S75–77. doi:10.1016/j.jaad.2007.05.017
   PubMed Web of Science ®Google Scholar
• Invernizzi P, Pasini S, Selmi C, Gershwin ME, Podda M. Female predominance and X chromosome defects in autoimmune diseases. J Autoimmun. 2009;33(1):12–16. doi:10.1016/j.jaut.2009.03.005
   PubMed Web of Science ®Google Scholar
• Lundin M, Chawa S, Sachdev A, Bhanusali D, Seiffert-Sinha K, Sinha AA. Gender differences in alopecia areata. J Drugs Dermatol. 2014;13(4):409–413.
   PubMed Web of Science ®Google Scholar
• Chitnis T. Role of puberty in multiple sclerosis risk and course. Clin Immunol. 2013;149(2):192–200. doi:10.1016/j.clim.2013.03.014
   PubMed Web of Science ®Google Scholar
• Cutolo M, Capellino S, Sulli A, et al. Estrogens and autoimmune diseases. Ann N Y Acad Sci. 2006;1089:538–547. doi:10.1196/annals.1386.043
   PubMed Web of Science ®Google Scholar
• Iamsumang W, Leerunyakul K, Suchonwanit P. Finasteride and its potential for the treatment of female pattern hair loss: evidence to date. Drug Des Devel Ther. 2020;14:951–959. doi:10.2147/dddt.S240615
   PubMed Web of Science ®Google Scholar
• Suchonwanit P, Iamsumang W, Rojhirunsakool S. Efficacy of topical combination of 0.25% finasteride and 3% minoxidil versus 3% minoxidil solution in female pattern hair loss: a randomized, double-blind, controlled study. Am J Clin Dermatol. 2019;20(1):147–153. doi:10.1007/s40257-018-0387-0
   PubMed Web of Science ®Google Scholar
• Kasumagic-Halilovic E, Prohic A. Nail changes in alopecia areata: frequency and clinical presentation. J Eur Acad Dermatol Venereol. 2009;23(2):240–241. doi:10.1111/j.1468-3083.2008.02830.x
   PubMed Web of Science ®Google Scholar
• Topal IO, Gungor S, Kocaturk OE, Duman H, Durmuscan M. Nail abnormalities in patients with vitiligo. An Bras Dermatol. 2016;91(4):442–445. doi:10.1590/abd1806-4841.20164620
   PubMed Web of Science ®Google Scholar
• Lee S, Kim BJ, Lee YB, Lee WS. Hair regrowth outcomes of contact immunotherapy for patients with alopecia areata: a systematic review and meta-analysis. JAMA Dermatol. 2018;154(10):1145–1151. doi:10.1001/jamadermatol.2018.2312
   PubMed Web of Science ®Google Scholar
• Mahasaksiri T, Kositkuljorn C, Anuntrangsee T, Suchonwanit P. Application of topical immunotherapy in the treatment of alopecia areata: a review and update. Drug Des Devel Ther. 2021;15:1285–1298. doi:10.2147/dddt.S297858
   PubMed Web of Science ®Google Scholar
• Sriphojanart T, Khunkhet S, Suchonwanit P. A retrospective comparative study of the efficacy and safety of two regimens of diphenylcyclopropenone in the treatment of recalcitrant alopecia areata. Dermatol Reports. 2017;9(2):7399. doi:10.4081/dr.2017.7399
   PubMed Web of Science ®Google Scholar
• Suchonwanit P, Kositkuljorn C, Mahasaksiri T, Leerunyakul K. A comparison of the efficacy and tolerability of three corticosteroid treatment regimens in patients with alopecia areata. J Dermatolog Treat. 2020;1–6. doi:10.1080/09546634.2020.1773384
   Web of Science ®Google Scholar
• Hordinsky M, Ericson M. Autoimmunity: alopecia areata. J Investig Dermatol Symp Proc. 2004;9(1):73–78. doi:10.1111/j.1087-0024.2004.00835.x
   PubMedGoogle Scholar
• Tan E, Tay YK, Goh CL, Chin Giam Y. The pattern and profile of alopecia areata in Singapore–a study of 219 Asians. Int J Dermatol. 2002;41(11):748–753. doi:10.1046/j.1365-4362.2002.01357.x
   PubMed Web of Science ®Google Scholar
• Xiao FL, Yang S, Liu JB, et al. The epidemiology of childhood alopecia areata in China: a study of 226 patients. Pediatr Dermatol. 2006;23(1):13–18. doi:10.1111/j.1525-1470.2006.00161.x
   PubMed Web of Science ®Google Scholar
• Kos L, Conlon J. An update on alopecia areata. Curr Opin Pediatr. 2009;21(4):475–480. doi:10.1097/MOP.0b013e32832db986
   PubMed Web of Science ®Google Scholar
• Mohan GC, Silverberg JI. Association of vitiligo and alopecia areata with atopic dermatitis: a systematic review and meta-analysis. JAMA Dermatol. 2015;151(5):522–528. doi:10.1001/jamadermatol.2014.3324
   PubMed Web of Science ®Google Scholar
• Betz RC, Pforr J, Flaquer A, et al. Loss-of-function mutations in the filaggrin gene and alopecia areata: strong risk factor for a severe course of disease in patients comorbid for atopic disease. J Invest Dermatol. 2007;127(11):2539–2543. doi:10.1038/sj.jid.5700915
   PubMed Web of Science ®Google Scholar
• Gilhar A, Paus R, Kalish RS. Lymphocytes, neuropeptides, and genes involved in alopecia areata. J Clin Invest. 2007;117(8):2019–2027. doi:10.1172/JCI31942
   PubMed Web of Science ®Google Scholar
• Barahmani N, Whaley K, Duvic M. Alopecia areata after allogeneic bone marrow transplantation from an affected, human leukocyte antigen-matched sibling. J Am Acad Dermatol. 2003;49(6):1192. doi:10.1016/S0190
   PubMed Web of Science ®Google Scholar
• McElwee KJ, Hoffmann R. Alopecia areata - animal models. Clin Exp Dermatol. 2002;27(5):410–417. doi:10.1046/j.1365-2230.2002.01075.x
   PubMed Web of Science ®Google Scholar
• Ker J, Hartert TV. The atopic march: what’s the evidence? Ann Allergy Asthma Immunol. 2009;103(4):282–289. doi:10.1016/S1081-1206(10)60526-1
   PubMed Web of Science ®Google Scholar
• Holgate ST. The epithelium takes centre stage in asthma and atopic dermatitis. Trends Immunol. 2007;28(6):248–251. doi:10.1016/j.it.2007.04.007
   PubMed Web of Science ®Google Scholar
• Saylam Kurtipek G, Cihan FG, Erayman Demirbas S, Ataseven A. The frequency of autoimmune thyroid disease in alopecia areata and vitiligo patients. Biomed Res Int. 2015;2015:435947. doi:10.1155/2015/435947
   PubMed Web of Science ®Google Scholar
• Conic RZ, Miller R, Piliang M, Bergfeld W, Atanaskova Mesinkovska N. Comorbidities in patients with alopecia areata. J Am Acad Dermatol. 2017;76(4):755–757. doi:10.1016/j.jaad.2016.12.007
   PubMed Web of Science ®Google Scholar
• Bin Saif GA. Severe subtype of alopecia areata is highly associated with thyroid autoimmunity. Saudi Med J. 2016;37(6):656–661. doi:10.15537/Smj.2016.6.13777
   PubMed Web of Science ®Google Scholar
• Han TY, Lee JH, Noh TK, et al. Alopecia areata and overt thyroid diseases: a nationwide population-based study. J Dermatol. 2018;45(12):1411–1417. doi:10.1111/1346-8138.14648
   PubMed Web of Science ®Google Scholar
• Andersen YM, Egeberg A, Gislason GH, Skov L, Thyssen JP. Autoimmune diseases in adults with atopic dermatitis. J Am Acad Dermatol. 2017;76(2):274–280 e271. doi:10.1016/j.jaad.2016.08.047
   PubMed Web of Science ®Google Scholar
• Drucker AM, Thompson JM, Li WQ, et al. Incident alopecia areata and vitiligo in adult women with atopic dermatitis: nurses’ Health Study 2. Allergy. 2017;72(5):831–834. doi:10.1111/all.13128
   PubMed Web of Science ®Google Scholar
• Cheong KA, Chae SC, Kim YS, Kwon HB, Chung HT, Lee AY. Association of thymic stromal lymphopoietin gene −847C>T polymorphism in generalized vitiligo. Exp Dermatol. 2009;18(12):1073–1075. doi:10.1111/j.1600-0625.2009.00897.x
   PubMed Web of Science ®Google Scholar
• Jariwala SP, Abrams E, Benson A, Fodeman J, Zheng T. The role of thymic stromal lymphopoietin in the immunopathogenesis of atopic dermatitis. Clin Exp Allergy. 2011;41(11):1515–1520. doi:10.1111/j.1365-2222.2011.03797.x
   PubMed Web of Science ®Google Scholar
• Bassiouny DA, Shaker O. Role of interleukin-17 in the pathogenesis of vitiligo. Clin Exp Dermatol. 2011;36(3):292–297. doi:10.1111/j.1365-2230.2010.03972.x
   PubMed Web of Science ®Google Scholar
• Eyerich K, Novak N. Immunology of atopic eczema: overcoming the Th1/Th2 paradigm. Allergy. 2013;68(8):974–982. doi:10.1111/all.12184
   PubMed Web of Science ®Google Scholar
• Suchonwanit P, Rojhirunsakool S, Khunkhet S. A randomized, investigator-blinded, controlled, split-scalp study of the efficacy and safety of a 1550-nm fractional erbium-glass laser, used in combination with topical 5% minoxidil versus 5% minoxidil alone, for the treatment of androgenetic alopecia. Lasers Med Sci. 2019;34(9):1857–1864. doi:10.1007/s10103-019-02783-8
   PubMed Web of Science ®Google Scholar
• Triyangkulsri K, Suchonwanit P. Role of janus kinase inhibitors in the treatment of alopecia areata. Drug Des Devel Ther. 2018;12:2323–2335. doi:10.2147/DDDT.S172638
   PubMed Web of Science ®Google Scholar
• Serarslan G, Savas N, Yenin JZ. Is atopy and autoimmunity more prevalent in patients with alopecia areata? A comparative study. J Eur Acad Dermatol Venereol. 2012;26(6):720–723. doi:10.1111/j.1468-3083.2011.04152.x
   PubMed Web of Science ®Google Scholar
• Kridin K, Shalom G, Comaneshter D, Cohen AD. Is there an association between alopecia areata and systemic lupus erythematosus? A population-based study. Immunol Res. 2020;68(1):1–6. doi:10.1007/s12026-020-09115-x
   PubMed Web of Science ®Google Scholar
• Desai MK, Brinton RD. Autoimmune disease in women: endocrine transition and risk across the lifespan. Front Endocrinol (Lausanne). 2019;10:265. doi:10.3389/fendo.2019.00265
   PubMed Web of Science ®Google Scholar
• Cardenas-Roldan J, Rojas-Villarraga A, Anaya JM. How do autoimmune diseases cluster in families? A systematic review and meta-analysis. BMC Med. 2013;11:73. doi:10.1186/1741-7015-11-73
   PubMed Web of Science ®Google Scholar
• Agre K, McCarthy Veach P, Bemmels H, Wiens K, LeRoy BS, Hordinsky M. Familial implications of autoimmune disease: recurrence risks of alopecia areata and associated conditions in first-degree relatives. J Genet Couns. 2020;29(1):35–43. doi:10.1002/jgc4.1178
   PubMed Web of Science ®Google Scholar
• Suchonwanit P, Udompanich S, Thadanipon K, Chanprapaph K. Trichoscopic signs in systemic lupus erythematosus: a comparative study with 109 patients and 305 healthy controls. J Eur Acad Dermatol Venereol. 2019;33(4):774–780. doi:10.1111/jdv.15421
   PubMed Web of Science ®Google Scholar
• Chanprapaph K, Udompanich S, Visessiri Y, Ngamjanyaporn P, Suchonwanit P. Nonscarring alopecia in systemic lupus erythematosus: a cross-sectional study with trichoscopic, histopathologic, and immunopathologic analyses. J Am Acad Dermatol. 2019;81(6):1319–1329. doi:10.1016/j.jaad.2019.05.053
   PubMed Web of Science ®Google Scholar
• Udompanich S, Chanprapaph K, Suchonwanit P. Hair and scalp changes in cutaneous and systemic lupus erythematosus. Am J Clin Dermatol. 2018;19(5):679–694. doi:10.1007/s40257-018-0363-8
   PubMed Web of Science ®Google Scholar
• Rutnin S, Chanprapaph K, Pakornphadungsit K, et al. Variation of hair follicle counts among different scalp areas: a quantitative histopathological study. Skin Appendage Disorders. 2021:1–7. doi:10.1159/000518434
   Web of Science ®Google Scholar
• Wong CK, Ho CY, Li EK, Lam CW. Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus. 2000;9(8):589–593. doi:10.1191/096120300678828703
   PubMed Web of Science ®Google Scholar
• Suchonwanit P, Chalermroj N, Khunkhet S. Low-level laser therapy for the treatment of androgenetic alopecia in Thai men and women: a 24-week, randomized, double-blind, sham device-controlled trial. Lasers Med Sci. 2019;34(6):1107–1114. doi:10.1007/s10103-018-02699-9
   PubMed Web of Science ®Google Scholar
• Thomas EA, Kadyan RS. Alopecia areata and autoimmunity: a clinical study. Indian J Dermatol. 2008;53(2):70–74. doi:10.4103/0019-5154.41650
   PubMedGoogle Scholar
• Chanprapaph K, Pomsoong C, Tankunakorn J, Eden C, Suchonwanit P, Rutnin S. Comparative Analyses of clinical features, histopathology, and CD123 Immunohistochemistry of oral lupus erythematosus, lichen planus, and other lichenoid lesions. Dermatology. 2021;1–12. doi:10.1159/000517971
   Web of Science ®Google Scholar
• Ippolito A, Wallace DJ, Gladman D, et al. Autoantibodies in systemic lupus erythematosus: comparison of historical and current assessment of seropositivity. Lupus. 2011;20(3):250–255. doi:10.1177/0961203310385738
   PubMed Web of Science ®Google Scholar
• Chan LS, Vanderlugt CJ, Hashimoto T, et al. Epitope spreading: lessons from autoimmune skin diseases. J Invest Dermatol. 1998;110(2):103–109. doi:10.1046/j.1523-1747.1998.00107.x
   PubMed Web of Science ®Google Scholar